FLASCO

Available Clinical Trials at UF Health Cancer Center

  • FLASCO
  • June 10, 2016

UF Health Cancer Center has several clinical trials in process, below please find information about four trials that are currently accepting participants:

ADU-CL-11
A Phase 1/2, Open-Label Safety and Efficacy Evaluation of CRS-207 in Combination With Epacadostat in Adults With Platinum-Resistant Ovarian, Fallopian, or Peritoneal Cancer.
https://clinicaltrials.gov/ct2/show/NCT02575807?term=adu-cl-11&rank=1 

ARGO
A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer.
https://clinicaltrials.gov/ct2/show/NCT02664077?term=argo&rank=3

JX594-HEP024
A Phase 3 Randomized, Open-Label Study Comparing Vaccinia Virus Based Oncolytic Immunotherapy (Pexa Vec, Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Followed by Sorafenib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) Without Prior Systemic Therapy.
https://clinicaltrials.gov/ct2/show/NCT02562755?term=jx594&rank=15

MATCH
NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
https://clinicaltrials.gov/ct2/show/NCT02465060?term=EAY131&rank=1
For more information about these or any other clinical trials available at UF Health please visit www.UFHealth.org/navigator, e-mail trials@cancer.ufl.edu, or call (352) 275-8675.

 

Who’s Online

There are no users currently online